The LSX Nordic Partnering and Investor Congress is in full swing in Copenhagen, and Sprint Bioscience is one of the attending companies. BioStock met with CEO Johan Emilsson and picked his brain on the market climate, the potential of preclinical partnering, and the development of the TREX-1 program.
See the full interview at biostock.se:
https://www.biostock.se/en/2024/10/sprint-bioscience-ceo-comments-on-deal-potential/
This is a press release from BioStock – Connecting Innovation & Capital. https://www.biostock.se
